AMSA Award For Impact in Healthcare 2026 Ceremony

16 hours ago
2 min read

AMSA held the 2026 AMSA Award For Impact in Healthcare Ceremony, bringing together researchers and members of the medical community to recognize the projects selected for this year’s award.

One of the highlights of the ceremony was a message from Pablo Legorreta Creel, Founder and Honorary Life Chairman, to this year’s award recipients. During his remarks, he shared three reflections on the path of conducting research:

“Number one, pursue the problem, not the publication. Always ask yourselves: if this works, how many patients will live better, and how much better? That number justifies everything else.”

“Number two, think in decades, not months. Almost every drug that transforms lives today took 10, 15, and even 25 years to reach patients. Persistence in the face of skepticism is not stubbornness; it is method.”

“Number three, do not work alone. The best ideas we have funded were born at the boundaries between disciplines and between countries. Collaborate, go out, and come back.”

His remarks encouraged the recipients to remain focused on the health problems their research seeks to address, take a long-term view of their work, and recognize the value of collaboration across disciplines and countries.

Presentation of the Awards

Following the remarks, Dr. David Kershenobich, Mexico’s Secretary of Health; Dr. Enrique Graue Wiechers, former Rector of the UNAM (2015–2023); Gerardo Legorreta Creel, President of AMSA; and Rebeca Aguilar-Álvarez de Sáenz, Executive Director of AMSA, presented the awards to the 2026 recipients of the AMSA Award for Impact in Healthcare.

First place was awarded to Dr. Ismael Mancilla Herrera, from the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, for his project:

“Immunological Clonal Profiling and Artificial Intelligence for the Prediction and Precision Management of Major Obstetric Syndromes in the Mexican Population.”

Second place was awarded to Dr. Guillermo de Anda Jáuregui, from the Instituto Nacional de Medicina Genómica, for his project:

“Multimodal Integration of Genomic and Imaging Data Through Artificial Intelligence to Improve Clinical Stratification in Breast Cancer.”

Third place was awarded to Dr. Ana Teresa Ochoa Guzmán, from the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, for her project:

“Development of an Integrated Cardiometabolic Risk Prediction Model Through the Combination of Polygenic Risk Scores (PRSs) and Cardiorespiratory Fitness in the Mexican Population.”

The three projects recognized this year address different health challenges and represent new lines of research that will continue to be developed with the support of the AMSA Award For Impact in Healthcare.

The ceremony concluded by recognizing the researchers’ work and marking the beginning of a new stage for the winning projects.